Hinz: When the government was buying vaccines, Rep. Newman traded in vaccine makers' stocks

  • Marie Newman

    Marie Newman

Updated 3/25/2022 5:46 PM

Locked into a tough primary race for re-election, U.S. Rep. Marie Newman has signed on to legislation that would ban the increasingly controversial practice of members of Congress trading stock in individual companies.

But Newman's conversion to that issue is recent -- very recent. Only in the last month have Newman and husband voluntarily ceased the practice themselves, this after trading stock worth $5.8 million in 2021. That was enough to rank her ninth among the 535 members of the House and Senate, right behind House Speaker Nancy Pelosi, who is eighth.


According to disclosures tracked by the Washington website Capitol Trades, they bought or sold tens of thousands of dollars of stock in Moderna, Pfizer and Johnson & Johnson, the three pharmaceutical firms whose anti-COVID vaccines were purchased in large numbers by the federal government after receiving approval from Congress.

Get the full Crain's Chicago Business report at chicagobusiness.com.

Article Comments
Guidelines: Keep it civil and on topic; no profanity, vulgarity, slurs or personal attacks. People who harass others or joke about tragedies will be blocked. If a comment violates these standards or our terms of service, click the X in the upper right corner of the comment box. To find our more, read our FAQ.